GARUX
Price
$11.41
Change
+$0.04 (+0.35%)
Updated
Jun 2 closing price
Net Assets
6.15B
RYMQX
Price
$24.05
Change
+$0.06 (+0.25%)
Updated
Jun 2 closing price
Net Assets
9.34M
Interact to see
Advertisement

GARUX vs RYMQX

Header iconGARUX vs RYMQX Comparison
Open Charts GARUX vs RYMQXBanner chart's image
GARUX vs RYMQX Comparison Chart in %
View a ticker or compare two or three
VS
GARUX vs. RYMQX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GARUX is a StrongBuy and RYMQX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GARUX has more cash in the bank: 6.15B vs. RYMQX (9.34M). RYMQX pays higher dividends than GARUX: RYMQX (9.67) vs GARUX (0.46). GARUX was incepted earlier than RYMQX: GARUX (11 years) vs RYMQX (21 years). RYMQX (2.06) is less costly to investors than GARUX (0.79). RYMQX is a more actively managed with annual turnover of: 154.00 vs. GARUX (134.00). RYMQX has a lower initial minimum investment than GARUX: RYMQX (2500) vs GARUX (5000000). GARUX annual gain was more profitable for investors over the last year : 12.91 vs. RYMQX (8.80). GARUX return over 5 years is better than : 17.75 vs. RYMQX (1.21).
GARUXRYMQXGARUX / RYMQX
Total Expense Ratio0.731.9937%
Annual Report Gross Expense Ratio0.792.0638%
Fund Existence11 years21 years-
Gain YTD6.3614.989128%
Front LoadN/A5%-
Min. Initial Investment50000002500200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.15B9.34M65,853%
Annual Yield % from dividends0.469.675%
Returns for 1 year12.918.80147%
Returns for 3 years29.485.04585%
Returns for 5 years17.751.211,470%
Returns for 10 years41.9623.85176%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCINX13.59N/A
N/A
VALIC Company I International Growth
FSMEX43.98N/A
N/A
Fidelity Select Medical Tech and Devcs
ISFIX20.51N/A
N/A
VY® Columbia Contrarian Core I
FRBRX189.71N/A
N/A
Franklin Biotechnology Discovery R6
JHEQX34.71N/A
N/A
JPMorgan Hedged Equity I